Brought to you by 
SmithKline spins-offf technology, forms Adprotech
13 Jul 1999
Executive Summary
SmithKline Beecham is spinning off some non-core technology to a new cardiovascular drug company called Adprotech, in exchange for a 10% stake. SB will also give the start-up some lab equipment.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SmithKline spins-offf technology, forms Adprotech
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice